vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Fold Holdings, Inc. (FLD). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $9.1M, roughly 1.0× Fold Holdings, Inc.). Foghorn Therapeutics Inc. runs the higher net margin — -234.3% vs -379.9%, a 145.6% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 8.2%). Over the past eight quarters, Fold Holdings, Inc.'s revenue compounded faster (36.1% CAGR vs 35.3%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Fold Holdings, Inc. is a U.S.-based fintech firm specializing in crypto-integrated consumer financial products. Its core offerings include a rewards debit card that provides Bitcoin and other cryptocurrency cashback on routine purchases, alongside user-friendly digital wallet tools for secure crypto storage, serving primarily the North American consumer market.
FHTX vs FLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $9.1M |
| Net Profit | $-21.7M | $-34.7M |
| Gross Margin | — | — |
| Operating Margin | -258.2% | -380.0% |
| Net Margin | -234.3% | -379.9% |
| Revenue YoY | 223.8% | 8.2% |
| Net Profit YoY | -11.1% | -7232.4% |
| EPS (diluted) | $-0.35 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $9.1M | ||
| Q3 25 | $8.2M | $7.4M | ||
| Q2 25 | $7.6M | $8.2M | ||
| Q1 25 | $6.0M | $7.1M | ||
| Q4 24 | $2.9M | $8.4M | ||
| Q3 24 | $7.8M | $5.2M | ||
| Q2 24 | $6.9M | $5.1M | ||
| Q1 24 | $5.0M | $4.9M |
| Q4 25 | $-21.7M | $-34.7M | ||
| Q3 25 | $-15.8M | $554.2K | ||
| Q2 25 | $-17.9M | $13.4M | ||
| Q1 25 | $-18.8M | $-48.9M | ||
| Q4 24 | $-19.5M | $486.4K | ||
| Q3 24 | $-19.1M | $-62.3M | ||
| Q2 24 | $-23.0M | $-2.3M | ||
| Q1 24 | $-25.0M | $-945.0K |
| Q4 25 | -258.2% | -380.0% | ||
| Q3 25 | -226.9% | 7.5% | ||
| Q2 25 | -279.2% | — | ||
| Q1 25 | -385.0% | -689.6% | ||
| Q4 24 | -840.5% | -9.1% | ||
| Q3 24 | -305.5% | -15.3% | ||
| Q2 24 | -386.6% | -12.2% | ||
| Q1 24 | -558.3% | -14.7% |
| Q4 25 | -234.3% | -379.9% | ||
| Q3 25 | -194.4% | 7.5% | ||
| Q2 25 | -237.3% | 164.2% | ||
| Q1 25 | -316.4% | -689.6% | ||
| Q4 24 | -682.9% | 5.8% | ||
| Q3 24 | -244.9% | -1188.7% | ||
| Q2 24 | -333.6% | -45.1% | ||
| Q1 24 | -495.4% | -19.2% |
| Q4 25 | $-0.35 | $-0.02 | ||
| Q3 25 | $-0.25 | $0.01 | ||
| Q2 25 | $-0.28 | $0.28 | ||
| Q1 25 | $-0.30 | $-1.92 | ||
| Q4 24 | $-0.23 | $0.09 | ||
| Q3 24 | $-0.31 | $-10.68 | ||
| Q2 24 | $-0.45 | $-0.40 | ||
| Q1 24 | $-0.59 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $7.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $63.0M |
| Total Assets | $198.1M | $153.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $7.7M | ||
| Q3 25 | $89.3M | $6.7M | ||
| Q2 25 | $72.6M | $6.6M | ||
| Q1 25 | $61.0M | $11.7M | ||
| Q4 24 | $55.5M | $18.3M | ||
| Q3 24 | $57.7M | — | ||
| Q2 24 | $138.9M | — | ||
| Q1 24 | $79.3M | — |
| Q4 25 | $-108.5M | $63.0M | ||
| Q3 25 | $-89.7M | $94.7M | ||
| Q2 25 | $-76.7M | $88.5M | ||
| Q1 25 | $-61.7M | $71.9M | ||
| Q4 24 | $-45.5M | $-67.8M | ||
| Q3 24 | $-28.3M | $-7.4M | ||
| Q2 24 | $-14.3M | $-74.0M | ||
| Q1 24 | $-97.5M | $-9.4M |
| Q4 25 | $198.1M | $153.5M | ||
| Q3 25 | $205.0M | $191.0M | ||
| Q2 25 | $226.2M | $182.1M | ||
| Q1 25 | $258.7M | $148.5M | ||
| Q4 24 | $284.0M | $125.7M | ||
| Q3 24 | $308.4M | $52.2M | ||
| Q2 24 | $328.6M | $51.8M | ||
| Q1 24 | $255.0M | $51.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-16.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-16.1M | ||
| Q3 25 | $-18.9M | $-2.5M | ||
| Q2 25 | $-21.0M | $-4.0M | ||
| Q1 25 | $-24.0M | $-5.0M | ||
| Q4 24 | $-24.5M | $-3.3M | ||
| Q3 24 | $-21.0M | $-2.2M | ||
| Q2 24 | $-25.5M | $-859.6K | ||
| Q1 24 | $-29.3M | $-354.2K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — | ||
| Q1 24 | $-29.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — | ||
| Q1 24 | -583.1% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.47× | ||
| Q2 25 | — | -0.30× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -6.82× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHTX
Segment breakdown not available.
FLD
| Banking And Payment Revenues | $8.4M | 92% |
| Other | $706.0K | 8% |
